DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"> News and Research - GUARD - Georgia United against Antibiotic Resistant Disease

GUARD is the Georgia chapter of the CDC's "Get Smart" (About Antibiotic Use) Program. The GUARD Coalition seeks to reduce antibiotic-resistant disease by decreasing inappropriate antibiotic use through educational campaigns and collaboration with community partners. Click here for more information about the CDC's "Get Smart" program.



RECENT NEWS AND RESEARCH

Entries in National News (10)

Hazards of Antibiotic Use

From August "Emergency Medicine Today", American College of Emergency Medicine

 Adverse effects from antibiotics send thousands to EDs annually, research indicates.

MedPage Today (8/13, Gever) reported that "[a]dverse effects from antibiotics led to more than 140,000 emergency [department] visits in the U.S. annually from 2004 through 2006, accounting for one-fifth of all such drug-related events," according to research published online in Clinical Infectious Diseases. Investigators "analyzed adverse-event data from the National Electronic Injury Surveillance System and Cooperative Adverse Drug Event Surveillance projects, developed by the CDC, the FDA, and the Consumer Product Safety Commission." The researchers "also used data on outpatient antibiotic prescription volume from several national surveys of ambulatory care providers." The "[d]ata...revealed a total of 6,614 visits related to outpatient antibiotic therapy, which was extrapolated to an annual national volume of 142,505 visits." The researchers found that "[a]llergic reactions accounted for an estimated 78.7 percent of antibiotic-related events." The investigators added that the "[a]ntibiotic classes most commonly involved with adverse events were the penicillins, fluoroquinolones, and cephalosporins, which were involved in 36.9 percent, 13.5 percent, and 12.2 percent of visits, respectively."

Posted on Thursday, August 14, 2008 at 09:36AM by Registered CommenterAdministrator in | CommentsPost a Comment | EmailEmail | PrintPrint

Review Article on Gram Negative Resistance

Resistance mechanisms among gram negative organisms have become more numerous and complex. This review article found on the Medscape web site is a nice synopsis for the interested reader. Paste this link into your web browser to download:

http://www.medscape.com/viewarticle/572674?src=mp&spon=17&uac=70149SJ

 

Posted on Friday, May 30, 2008 at 04:16PM by Registered CommenterAdministrator in | CommentsPost a Comment | EmailEmail | PrintPrint

Study suggests linezolid may be as effective as vancomycin for treating patients with complicated skin, soft tissue infections caused by MRSA.

 (From "Emergency Medicine Today", April 22 2008)

Medscape (4/21, Berrie) reported that "[t]he oxazolidinone antibiotic linezolid is at least as effective as vancomycin for the treatment of patients with complicated skin and soft tissue infections (cSSTIs) that are proven to be caused by methicillin-resistant Staphylococcus aureus (MRSA), according to" a study presented in Barcelona at the 18th European Congress of Clinical Microbiology and Infectious Diseases. Kamal M. F. Itani, M.D., of the Philadelphia Veteran's Affairs Medical Center, Pennsylvania, and colleagues randomly assigned more than 1,000 "patients...to receive either linezolid (n=544), 600 mg intravenously (IV) or orally every 12 hours, or vancomycin (n=533) IV every 12 hours." These "treatments were continued for seven to 14 days." Dr. Itani said that "[l]inezolid proved to be at least as effective as vancomycin, with higher numerical success rates at" the end of the study "for the treatment of cSSTIs caused by MRSA."

Posted on Tuesday, April 22, 2008 at 09:30AM by Registered CommenterAdministrator in | CommentsPost a Comment | References8 References | EmailEmail | PrintPrint

Universal MRSA Screening May Not Be Best Course

Study suggests MRSA screening at hospital admission may not curb infection rates. Reuters (3/12, Stern) reports that testing "all incoming hospital patients for" methicillin-resistant Staphylococcus aureus (MRSA) "and isolating those infected did not curtail its spread, and proved costly," according to a study published in the Mar. 12 issue of the Journal of the American Medical Association.

Click to read more ...

Posted on Wednesday, March 12, 2008 at 10:53AM by Registered CommenterAdministrator in | CommentsPost a Comment | EmailEmail | PrintPrint

MRSA Co-infection in Children with Influenza

CDC is requesting that states report all cases of influenza-related pediatric mortality during the 2007-2008 influenza season. This health advisory contains updated information about influenza and bacterial co-infections in children and provides interim testing and treatment recommendations.

Click to read more ...

Posted on Friday, February 1, 2008 at 11:38AM by Registered CommenterAdministrator in | CommentsPost a Comment | References33 References | EmailEmail | PrintPrint

Antibiotics Don't Necessarily Help in Sinusitis

Some antibiotics may be ineffective against acute sinusitis, study indicates. The AP (12/5, Tanner) reports that according to a study published in today's issue of the Journal of the American Medical Association, "people suffering from facial pain and a runny nose with greenish or yellowish mucus generally improved within about two weeks -- whether they took the standard antibiotic amoxicillin, steroid nose spray [budesonide], or fake medicine." This finding may have important implications for antibiotics, "particularly the penicillin-like drug amoxicillin," which "are among the most commonly prescribed medicines for sinus infections." Dr. Vincenza Snow, a Philadelphia internist and director of clinical programs and quality of care at the American College of Physicians, points out that "while antibiotics are designed to treat bacteria, these drugs aren't always very effective at treating bacterial sinus infections because the medicine has a tough time reaching the sinuses."

Click to read more ...

Posted on Saturday, January 26, 2008 at 07:58PM by Registered CommenterAdministrator in | CommentsPost a Comment | References1 Reference | EmailEmail | PrintPrint

Garlic vs MRSA

 From "Emergency Medicine Today", an online newsletter of the American College of Emergency Physicians.

Garlic may combat MRSA, study suggests.

The Chicago Tribune (11/14, Deardorff) reports, "Garlic, well known for its natural antibiotic properties, contains an ingredient that has been shown to effectively kill methicillin-resistant Staphylococcus aureus (MRSA)," according to several studies. The Chinese first mentioned garlic "2,000 years ago in...medical literature," and Aristotle and Hippocrates also used the pungent remedy. Ron Cutler of the University of East London "published research in 2004" that showed the compound allicin, which is found in garlic, "kills several different strains of MRSA." Garlic "can be used as an antiseptic and antibacterial because it stops micro-organisms such as bacteria from reproducing." Another advantage of garlic is that "unlike modern antibiotics, the body does not seem to build up a resistance to garlic," according to researchers. Currently, investigators, "including Cutler, are working to develop so-called stabilized allicin products, including spraying liquids, creams and oral capsules."

Posted on Wednesday, November 14, 2007 at 10:22AM by Registered CommenterAdministrator in | CommentsPost a Comment | EmailEmail | PrintPrint

American Academy of Pediatrics: Statement on MRSA in Schools

This information sheet from the AAP addresses concerns of parents and school officials regarding pupils who have been diagnosed with skin infection from MRSA. Recommendations are provided for dealing with the infected pupil. Note that like the CDC, the AAP does not recommend exclusion from school. Click here to read more.

Posted on Friday, November 9, 2007 at 04:58PM by Registered CommenterAdministrator in | CommentsPost a Comment | EmailEmail | PrintPrint

Invasive Methicillin-Resistant Staphylococcus aureus Infections in the United States

A new report from the Journal of the American Medical Association (JAMA) describes the incidence and distribution of invasive MRSA disease in the United States. Extrapolation from the 9 metro regions studied revealed that between 10,000 and 20,000 Americans die from invasive MRSA each year. Approximately 4-6% of these infections were community associated, and more than 90% were healthcare associated.

For more details click here to see a PDF version of "Invasive MRSA infections in the United States" by Klevens et al. in the October 19 2007 issue of JAMA. This link is made available by the CDC.

Posted on Tuesday, October 30, 2007 at 08:59AM by Registered CommenterAdministrator in | CommentsPost a Comment | EmailEmail | PrintPrint

Antibotics Aren't Always the Answer

Your throat feels as if you've swallowed broken glass, your sinuses have been clogged for a couple of days, you're coughing up green stuff and you're slated to fly in a week. Never mind that your doctor thinks you're suffering from a viral infection that antibiotics won't touch. Why not start a prescription of some powerful bacteria-busting drug immediately, just in case?

Click to read more ...

Posted on Tuesday, July 18, 2006 at 04:30PM by Registered CommenterAdministrator in | CommentsPost a Comment | EmailEmail | PrintPrint